Pulmonary, Hepatic and Endocrine Pharmacology

CCR3 monoclonal antibody inhibits airway eosinophilic inflammation and mucus overproduction in a mouse model of asthma



To explore the effect of a rat anti-mouse CC-chemokine receptor-3 (CCR3) monoclonal antibody (CCR3 mAb) on airway eosinophilia and mucus overproduction in asthmatic mice.


An asthma model was sensitized and challenged by ovalbumin (OVA) in male C57BL/6 mice. Asthmatic mice were given dual administration (intraperitoneal injection and aerosol inhalation) of CCR3 mAb or nonspecific rat IgG (ns-IgG). The number of total and differential inflammatory cells in the bronchial alveolar lavage fluid (BALF) was counted. Eosinophils number, the goblet cell percentage (GCP) and airway mucus index (AMI) were measured in the lung tissues. Interleukin (IL)-5 levels in the BALF were examined. The expression of MUC5AC and the epidermal growth factor receptor (EGFR) mRNA in the lung tissues was detected by semi-quantitative RT-PCR. The results were compared among the groups.


CCR3 mAb significantly suppressed the increased eosinophils in the BALF and lung tissues in OVA-challenged mice compared with ns-IgG-treated mice. IL-5 levels in the BALF in CCR3 mAb and ns-IgG administration mice exhibited no obvious changes relative to OVA-challenged asthmatic mice. CCR3 mAb reduced the increased GCP and AMI after OVA challenge and decreased the enhanced expression of MUC5AC and EGFR mRNA in lung tissues in asthmatic animals.


CCR3 mAb can significantly inhibit airway eosinophilia and mucus overproduction in asthmatic mice. Blockage of CCR3 may represent a new strategy to asthma therapy.


  1. 1

    Lungarella G, Menegazzi R, Gardi C, Spessotto P, de Santi MM, Bertoncin P, et al. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch Biochem Biophys 1992; 292: 128–35.

    CAS  Article  Google Scholar 

  2. 2

    Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR, et al. Defining a link with asthmain mice congenitally deficient in eosinophils. Science 2004; 305: 1726–9.

    Article  Google Scholar 

  3. 3

    Grimaldi JC, Yu NX, Grunig G, Seymour BW, Cottrez F, Robinson DS, et al. Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J Leukoc Biol 1999; 65: 846–53.

    CAS  Article  Google Scholar 

  4. 4

    Kibe A, Inoue H, Fukuyama S, Machida K, Matsumoto K, Koto H, et al. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 2003; 167: 50–6.

    Article  Google Scholar 

  5. 5

    Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 1999; 96: 3081–6.

    CAS  Article  Google Scholar 

  6. 6

    Justice JP, Borchers MT, Crosby JR, Hines EM, Shen HH, Ochkur SI, et al. Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. Am J Physiol Lung Cell Mol Physiol 2003; 284: 169–78.

    Article  Google Scholar 

  7. 7

    Shen HH, Ochkur SI, McGarry MP, Crosby JR, Hines EM, Borchers MT, et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003; 170: 3296–305.

    CAS  Article  Google Scholar 

  8. 8

    Honda J, Oomizu S, Kiuchi Y, Komatsu N, Takeuchi S, Takahashi S . Identification of epidermal growth factor mRNA-expressing cells in the mouse anterior pituitary. Neuroendocrinology 2000; 71: 155–62.

    CAS  Article  Google Scholar 

  9. 9

    Leckie MJ . Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models. Am J Respir Med 2003; 2: 245–59.

    CAS  Article  Google Scholar 

  10. 10

    Lee NA, Gelfand EW, Lee JJ . Pulmonary T cells and eosinophils: Coconspirators or independent triggers of allergic respiratory pathology?. J Allergy Clin Immunol 2001; 107: 945–7.

    CAS  Article  Google Scholar 

  11. 11

    Elsner J, Escher SE, Forssmann U . Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy 2004; 59: 1243–58.

    CAS  Article  Google Scholar 

  12. 12

    Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 1997; 100: 1137–43.

    CAS  Article  Google Scholar 

  13. 13

    Sallusto F, Mackay CR, Lanzavecchia A . Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 2005–200.

    CAS  Article  Google Scholar 

  14. 14

    Humbles AA, Lu B, Friends DS, Okinaga S, Lora J, Al-Garawi A, et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci USA 2002; 99: 1479–84.

    CAS  Article  Google Scholar 

  15. 15

    Das AM, Vaddi KG, Solomon KA, Krauthauser C, Jiang X, McIntyre KW, et al. Selective inhibition of eosinophil influx into the lung by small molecule CCR3 antagonists in mouse models of allergic inflammation. J Pharmacol Exp Ther 2006; 318: 411–7.

    CAS  Article  Google Scholar 

  16. 16

    Shi HZ . Eosinophils function as antigen-presenting cells. J Leukoc Biol 2004; 76: 520–7.

    CAS  Article  Google Scholar 

  17. 17

    Xie ZF, Shi HZ, Qin XJ, Kang LF, Huang CP, Chen YQ . Effects of antigen presentation of eosinophils on lung Th1/Th2 imbalance. Chin Med J 2005; 118: 6–11.

    CAS  PubMed  Google Scholar 

  18. 18

    van Rijt LS, Vos N, Hijdra D, de Vries VC, Hoogsteden HC, Lambrecht BN . Airway eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T cells. J Immunol 2003; 171: 3372–8.

    CAS  Article  Google Scholar 

  19. 19

    Rogers DF . Airway hypersecretion in allergic rhinitis and asthma: new pharmacotherapy. Curr Allergy Asthma Rep 2003; 3: 238–48.

    Article  Google Scholar 

  20. 20

    Jackson AD . Airway goblet-cell mucus secretion. Trends Pharmacol Sci 2001; 22: 39–45.

    CAS  Article  Google Scholar 

  21. 21

    Rogers DF . Pharmacological regulation of the neuronal control of airway mucus secretion. Curr Opin Pharmacol 2002; 2: 249–55.

    CAS  Article  Google Scholar 

  22. 22

    Nadel JA, Burgel PR . The role of epidermal growth factor in mucus production. Curr Opin Pharmacol 2001; 1: 254–8.

    CAS  Article  Google Scholar 

  23. 23

    Takeyama K, Fahy JV, Nadel JA . Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med 2001; 163: 511–6.

    CAS  Article  Google Scholar 

  24. 24

    Burgel PR, Lazarus SC, Tam DC, Ueki IF, Atabai K, Birch M, et al. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J Immunol 2001; 167: 5948–54.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding authors

Correspondence to Hua-hao Shen or Feng Xu.

Additional information

Project supported in part by the National Natural Science Foundation of China (No 30570807), key programs of the Natural Science Foundation of Zhejiang Province, China (No Z303761) and key programs of Science and Technology Association of Zhejiang Province (No 2003C24002).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shen, Hh., Xu, F., Zhang, Gs. et al. CCR3 monoclonal antibody inhibits airway eosinophilic inflammation and mucus overproduction in a mouse model of asthma. Acta Pharmacol Sin 27, 1594–1599 (2006). https://doi.org/10.1111/j.1745-7254.2006.00446.x

Download citation


  • asthma
  • CCR3 monoclonal antibody
  • eosinophilic inflammation
  • mucus overproduction
  • MUC5AC
  • epidermal growth factor receptor

Further reading